Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of “Moderate Buy” by Brokerages

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has received an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price […]

Leave a Reply

Your email address will not be published.

Previous post LegalZoom.com (NASDAQ:LZ) and Relo Group (OTCMKTS:RELOF) Head-To-Head Review
Next post Kinaxis (KXS) Scheduled to Post Earnings on Wednesday